Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Drug Resistance

Free Subscription 23.03.2026 3 Clin Infect Dis 4 Int J Antimicrob Agents 7 J Antimicrob Chemother 2 J Clin Microbiol 2 J Infect Chemother 15 J Infect Dis 1 J Med Microbiol 1 Nat Med 1 PLoS Biol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Infect Dis

1. ROLLE C, Achhra A, Harbison C, Finkel D, et al
   Combined use of ibalizumab and lenacapavir for the treatment of multidrug-resistant HIV-1: A case series.
   Clin Infect Dis. 2025 Nov 3:ciaf597. doi: 10.1093.
   PubMed         Abstract available
   
   
2. BOUILLER K, Cella E, Jacko NF, Hiehle ME, et al
   Comparing Clinical, Microbiological, and Genetic Definitions of Relapse in Patients With Subsequent Episodes of Methicillin-resistant Staphylococcus aureus Bone and Joint Infection.
   Clin Infect Dis. 2026;82:402-410.
   PubMed         Abstract available
   
   
3. CASTILLO AY, Jenkins TC, Axelrath S, Barocas JA, et al
   Street Stewardship: The next frontier to address antibiotic resistance and health inequities.
   Clin Infect Dis. 2026 Mar 21:ciag177. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Int J Antimicrob Agents

4. OU H, Shen S, Tang C, Yang W, et al
   Identification of KPC-271, a novel KPC variant conferring ceftazidime-avibactam resistance while restoring carbapenem susceptibility in ST15-KL19 Klebsiella pneumoniae.
   Int J Antimicrob Agents. 2026;67:107725.
   PubMed         Abstract available
   
   
5. FALAGAS ME, Romanos LT, Katritsi ED, Tzvetanova ID, et al
   Resistance of uropathogens to gepotidacin: A systematic review of in vitro antimicrobial susceptibility studies.
   Int J Antimicrob Agents. 2026;67:107723.
   PubMed         Abstract available
   
   
6. LU R, Wu Y, Ma R, Feng R, et al
   Ceftazidime/Avibactam-Resistant Carbapenem-Resistant Klebsiella pneumoniae in China: A Nationwide Multicenter Study.
   Int J Antimicrob Agents. 2026 Mar 16:107774.
   PubMed         Abstract available
   
   
7. VARNADO A, Moheb S, Sanchez SD, Rodriguez C, et al
   Human serum albumin and biological fluids reduce cefiderocol activity in carbapenem-resistant Gram-negative bacteria.
   Int J Antimicrob Agents. 2026 Mar 12:107781.
   PubMed         Abstract available
   
   

   
   J Antimicrob Chemother

8. RU S, Zhang Y
   Comment on: Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched-cohort study.
   J Antimicrob Chemother. 2026;81:dkag096.
   PubMed        
   
   
9. ARMENIA D, Alteri C, Micheli V, Allice T, et al
   Evaluation of HIV-1 transmitted drug-resistance among subtypes circulating from 2022 to 2024 in Italy: a refined analysis through next-generation sequencing.
   J Antimicrob Chemother. 2026;81:dkag084.
   PubMed         Abstract available
   
   
10. SANCAK B, Kirbas E, Ari O, Durmaz R, et al
    Genomic characterization of colistin heteroresistance in Acinetobacter baumannii: Evidence for lpxD deletion and collateral sensitivity.
    J Antimicrob Chemother. 2026;81:dkag076.
    PubMed         Abstract available
    
    
11. YAO H, Li W, Chen M, Zhang C, et al
    Characterization of efflux pump channel of florfenicol for resistance-enhancing variant RE-CmeABC in Campylobacter.
    J Antimicrob Chemother. 2026;81:dkag047.
    PubMed         Abstract available
    
    
12. DAMSTE C, Stoorvogel H, Oerlemans A, Knippenberg M, et al
    Healthcare providers' experiences in caring for MDRO carriers with a focus on the moral dimensions of care: a systematic review.
    J Antimicrob Chemother. 2026;81:dkag059.
    PubMed         Abstract available
    
    
13. BEH JQ, Howden BP, Webb JR, Connor CH, et al
    Global dissemination of optrA-mediated linezolid resistance in enterococci.
    J Antimicrob Chemother. 2026;81:dkag089.
    PubMed         Abstract available
    
    
14. WAN L, Li X, Zheng X, Chen T, et al
    Genomic insights into the tmexCD-toprJ: plasmid-mediated evolution, dissemination and diversity in bacterial populations.
    J Antimicrob Chemother. 2026;81:dkag107.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

15. SIMNER PJ
    The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance.
    J Clin Microbiol. 2026 Mar 18:e0045125. doi: 10.1128/jcm.00451.
    PubMed         Abstract available
    
    
16. PATEL K, Shea J, Lapierre P, Halse TA, et al
    Predicting isoniazid resistance in Mycobacterium tuberculosis complex in New York State using whole-genome sequencing.
    J Clin Microbiol. 2026 Mar 18:e0160925. doi: 10.1128/jcm.01609.
    PubMed         Abstract available
    
    

    
    J Infect Chemother

17. MAKINO J, Honda M, Sato F, Morikawa Y, et al
    Clinical impact of antimicrobial de-escalation in critically ill patients: A single-center cohort study.
    J Infect Chemother. 2026;32:102946.
    PubMed         Abstract available
    
    
18. ANRAKU M, Nakano S, Yamaguchi T, Nishijima S, et al
    Molecular characterization of O25:H4 ST131 extraintestinal pathogenic Escherichia coli (ExPEC) harboring a bla(OXA-48)-carrying IncFII plasmid.
    J Infect Chemother. 2026;32:102941.
    PubMed         Abstract available
    
    

    
    J Infect Dis

19. YANG Y, Qin J, Hu Y, Wang J, et al
    Carbapenem-Resistant Klebsiella pneumoniae of Sequence Type 11: A Scoping Review.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
20. HU Y, Fang Q, Zhang L, He Y, et al
    Clinical Outcomes in Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Infection: A Cohort Study.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
21. LIAO Q, Ma Z, Kang M, Xie Y, et al
    Clinical and Molecular Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Teaching Hospital.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
22. ZHANG B, Xu W, Zhang X, Zhang Q, et al
    Reduced Susceptibility to Cefepime-Taniborbactam in Carbapenem-Resistant Klebsiella pneumoniae Attributed to Penicillin-Binding Protein 3 Modifications.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
23. LI J, Fang Q, Luo H, Feng Y, et al
    Isolation of Lytic Bacteriophages Against Carbapenem-Resistant Klebsiella pneumoniae of Capsular Type KL64 From Water Collected at Multiple Sites Across China.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
24. TAM KK, Suster CJE, Fong W, Golubchik T, et al
    Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 Epidemic.
    J Infect Dis. 2026 Mar 21:jiag163. doi: 10.1093.
    PubMed         Abstract available
    
    
25. FLERES G, Cheng S, Badrane H, Dupont CL, et al
    Blood cultures contain populations of genetically diverse Candida albicans strains that may differ in echinocandin tolerance and fitness.
    J Infect Dis. 2025 Sep 30:jiaf495. doi: 10.1093.
    PubMed         Abstract available
    
    
26. LI Y, Cai H, Hua X, Yu Y, et al
    Challenges and Strategies in Managing beta-Lactam-Resistant Pseudomonas aeruginosa in China.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
27. QIN J, Feng Y, Yang Y, McNally A, et al
    OmpK35 and OmpK36 Deficiencies Driving High-level Carbapenem Resistance in ST11 Klebsiella Pneumoniae.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
28. ZENG Y, He Y, Ma K, Feng Y, et al
    Aztreonam-Avibactam Resistance Due to Synergistic Interplay of ampC-Related Mutations in Carbapenem-Resistant Enterobacter spp.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
29. GUO Y, Ding L, Zhou Y, Ren X, et al
    Trends of Carbapenem-Resistant Gram-negative Bacteria in China: A Surveillance Study Between 2015 and 2024.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
30. LIANG L, Feng Y, Jiang Y, Zhou W, et al
    New Delhi Metallo-beta-Lactamase Carbapenem-Resistant Klebsiella pneumoniae in Neonates: A Genome-Based Surveillance Study.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
31. ZHOU J, Tang X, He L, Zhang F, et al
    Molecular Mechanisms of beta-Lactam Resistance and Its Contribution to Multidrug Resistance in Helicobacter pylori.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
32. ZHANG Y, He J, Sun L, Yu Q, et al
    Molecular Epidemiology and Persistence of Multidrug-Resistant Acinetobacter baumannii in Zhejiang, China (2015-2020): Insights Into Resistance, Virulence, and Transmission Dynamics.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    
33. WANG J, Zhang X, Zhang Y, Xie Q, et al
    Emergence of Carbapenem-Resistant Escherichia coli Coharboring blaCTX-M-199 and Penicillin-Binding Protein 3 Insertion Conferring Increased Aztreonam/Avibactam Resistance in South China.
    J Infect Dis. 2026;233.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

34. SWIFT C, Jenkins C, Chattaway MA, Wong V, et al
    A 5-year review of Helicobacter pylori isolated from gastric biopsies at the UK Health Security Agency Gastrointestinal Bacteria Reference Unit.
    J Med Microbiol. 2026;75:002142.
    PubMed         Abstract available
    
    

    
    Nat Med

35. DOAN T, Yan D, Arzika AM, Abdou A, et al
    Mass azithromycin distribution and antibiotic resistance in the gut and nasopharynx: a cluster-randomized trial.
    Nat Med. 2026;32:859-868.
    PubMed         Abstract available
    
    

    
    PLoS Biol

36. HSIEH YP, O'Keefe IP, Wang Z, Sun W, et al
    Magnesium depletion by Candida albicans unleashes two unusual modes of colistin resistance in Pseudomonas aeruginosa with different fitness costs.
    PLoS Biol. 2026;24:e3003673.
    PubMed         Abstract available
    
    

    
    PLoS One

37. ASHLEY-AGBEDOR IE, Mahazu S, Kotey FCN, Amedior J, et al
    Genomic characterisation of extensively drug-resistant Acinetobacter baumannii isolates from a tertiary hospital in Ghana.
    PLoS One. 2026;21:e0336931.
    PubMed         Abstract available
    
    
38. OMBAJO LA, Nkuranga J, Penner J, Kamau EW, et al
    The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol.
    PLoS One. 2026;21:e0330792.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum